Vortioxetine Can Be Used Safely to Treat Depression After Implantable Cardioverter Defibrillator Implantation for Congenital Long <scp>QT</scp> Syndrome: A Case Report
After ICD implantation, a patient's mental status should be monitored carefully. Our findings suggest that vortioxetine may be a safe treatment option for depression associated with congenital LQTS.
Authors
- Masanobu Yamauchi (ORCID: https://orcid.org/0000-0003-1612-2654)
- Michiharu Nagahama
- Junya Tanabe (ORCID: https://orcid.org/0000-0001-8263-6077)
- Koji Otsuki (ORCID: https://orcid.org/0000-0002-0980-3614)
- Kouhei Sato
- Masatoshi Inagaki (ORCID: https://orcid.org/0000-0002-9822-8649)
Institutions
- Shimane University (JP)
Publication Details
- Journal
- Neuropsychopharmacology Reports
- Published
- 2025-04-23
- DOI
- https://doi.org/10.1002/npr2.70017
- Citations
- 2
- Primary Topic
- Cardiac electrophysiology and arrhythmias
- Type
- article
- Field-Weighted Citation Impact
- 2.78